Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Replidyne logo — Developing groundbreaking anti-infective products through pr...

Replidyne

Developing groundbreaking anti-infective products through proprietary DNA replication technology and strategic in-licensing.

Founded 2000 Series A Total: $13.00M Biopharma, Biotechnology

General Information

Company Name Replidyne
Founded Year 2000
Industries Biopharma, Biotechnology
Funding Stage Series A
Social

Get notified when Replidyne moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Replidyne

Replidyne is a pharmaceutical company specializing in the development and commercialization of innovative anti-infective products. The company, founded in 2000, is focused on developing groundbreaking anti-infective products through proprietary DNA replication technology and strategic in-licensing efforts. Their development pipeline is based on this proprietary DNA replication technology and strategic in-licensing, positioning them as a leader in the Biopharma and Biotechnology industries. In April 2002, Replidyne secured a $13.00M Series A investment from notable investors including HealthCare Ventures, Morgenthaler Ventures, Sequel Venture Partners, and Johnson & Johnson Development Corporation. This investment signifies a strong show of confidence in Replidyne's innovative approach to tackling infectious diseases. The support from these prominent investors further validates Replidyne's potential for growth and success in the biopharmaceutical industry.

Taxonomy: pharmaceutical company, anti-infective products, innovation, DNA replication technology, specialty pharmaceuticals, proprietary technology, development pipeline, in-licensing, commercialization, drug development

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 4
Investor Investor Investor Investor
19 Apr 2002

Replidyne Alternatives & Competitors

Replidyne vs
Bluepixel Technologies LLP
Bluepixel Technologies LLP India

Mobile App Development company specializing in developing App based on Bluetooth/BLE, Beacon, NFC, R...

40 employees
Mobile
Replidyne vs
Devstark
Devstark Romania

Custom software development services and technology consulting.

22 employees
Replidyne vs
DEIENAMI
DEIENAMI India

App & Web Development Company

15 employees
Information Technology, Internet

FAQ About Replidyne

Developing groundbreaking anti-infective products through proprietary DNA replication technology and strategic in-licensing.
Replidyne was founded in 2000.
Replidyne operates in the following industries: Biopharma, Biotechnology.
Replidyne has completed 1 funding round, raising a total of $13.00M. The latest funding stage is Series A.
Top alternatives and competitors to Replidyne include Bluepixel Technologies LLP, Devstark, DEIENAMI, Optibytes Digital Technologies, Gamnes & Bror AS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Replidyne and Bluepixel Technologies LLP are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Replidyne and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes